GLP-1 Medications for Menopause Weight Loss

Menopause often leads to weight gain due to hormonal and metabolic changes, affecting around 70% of women. GLP-1 medications offer a promising solution by mimicking hormones that regulate appetite and metabolism. Women using these treatments have achieved weight loss of up to 16%, especially when combined with hormone therapy. In Singapore, options like semaglutide (Wegovy, Ozempic) and tirzepatide (Mounjaro) are available via MOH-approved clinics, starting from S$350/month. These treatments also improve metabolic and cardiovascular health, addressing key menopause-related challenges.

Key points:

• Weight Loss: Up to 22.5% (tirzepatide) and 15.8% (semaglutide) over 68–72 weeks.
• Health Benefits: Improved insulin sensitivity, reduced HbA1c, cholesterol, and cardiovascular risks.
• Singapore Access: Prescription-only via licensed clinics like Trimly, offering online consultations and personalised care.
• Lifestyle Support: Best results when combined with diet, exercise, and (optionally) hormone therapy.

GLP-1 medications provide a science-backed approach to managing menopause weight gain, with broad health benefits beyond weight loss.

Weight Gain During Menopause: Solutions in the Era of GLP1-agonists

Clinical Studies on GLP-1 Medications for Menopause

Extensive clinical trials have shown that GLP-1 medications are highly effective in promoting weight loss among menopausal and perimenopausal women.

Tirzepatide and SURMOUNT Trials

The SURMOUNT-1 trial provided detailed insights into how tirzepatide performs across different reproductive stages. The results were impressive: postmenopausal women experienced a 23% reduction in body weight, compared to just 3% for those on placebo. Perimenopausal women saw the same 23% reduction, while premenopausal women achieved slightly higher results at 26%.

Waist circumference also showed a significant decrease - by 20 cm - in both peri- and postmenopausal groups. Nearly all participants, around 97–98%, achieved at least 5% weight loss with tirzepatide.

"Tirzepatide treatment was associated with significant body weight, waist circumference, and WHtR reductions versus placebo in women living with obesity or overweight and without type 2 diabetes, irrespective of reproductive stage." – Beverly G. Tchang, MD, Weill Cornell Medicine

In a direct comparison (SURMOUNT-5), tirzepatide outperformed semaglutide, achieving a 20.2% weight loss versus 13.7% over 72 weeks. Waist circumference reductions were also more pronounced: 18.4 cm with tirzepatide compared to 13.0 cm with semaglutide.

These findings highlight tirzepatide’s potential as a leading GLP-1 option, setting a benchmark for comparisons with other treatments like semaglutide.

Semaglutide Studies in Menopausal Women

Semaglutide has also shown strong efficacy in menopausal women, particularly in long-term weight management. The SELECT trial, which tracked participants for 208 weeks (four years), demonstrated that women achieved a mean weight loss of 11.1%, significantly higher than the 7.5% observed in men. This sustained weight loss is especially valuable for addressing the challenges of maintaining weight reduction during menopause.

Postmenopausal women, despite having a higher baseline weight, responded well to semaglutide. Over four months, they lost an average of 5.9 kg, which was comparable to the 4.5 kg lost by premenopausal women.

"Despite a greater initial weight and fat mass among postmenopausal women, after 4 months of treatment with semaglutide 1 mg, either fat mass loss or weight loss were similar to premenopausal women." – Joana Nicolau, MD, PhD, Hospital Universitario Son Llàtzer

In addition to weight loss, the SELECT trial revealed notable cardiovascular benefits. Semaglutide users experienced a 20% reduction in major adverse cardiovascular events, a critical factor given the increased cardiovascular risk after menopause. Participants also saw a mean waist circumference reduction of 7.7 cm by the end of the 208-week trial.

Health Benefits of GLP-1 Medications Beyond Weight Loss

GLP-1 medications do more than just help with weight loss - they tackle the metabolic and cardiovascular challenges that often arise during menopause. For women navigating this stage of life, these benefits can be especially impactful.

Improvements in Metabolic Health

GLP-1 medications play a key role in restoring metabolic balance during menopause. They stimulate insulin release, suppress excess glucagon, and slow down gastric emptying. This combination is particularly helpful as menopausal women often experience a shift towards central fat storage.

The results are impressive. For instance, semaglutide has been shown to reduce HbA1c levels by 1.0–2.0%, significantly lowering the risk of developing type 2 diabetes. Even a modest 5% weight loss achieved with these medications can enhance multi-organ insulin sensitivity and improve β-cell function. Beyond glucose control, GLP-1 treatments also improve cholesterol levels by lowering total cholesterol, LDL, and triglycerides, addressing common metabolic concerns during menopause.

"Even a modest weight loss of 5% has been shown to improve cardiometabolic risk factors, including reduced systolic blood pressure and plasma triglyceride concentration, and increased multi-organ insulin sensitivity and β-cell function." – Jamy Ard, Division of Public Health Sciences, Wake Forest University School of Medicine

These metabolic benefits are closely tied to cardiovascular health improvements, which are equally crucial for menopausal women.

Cardiovascular Health Benefits

For women facing a heightened risk of heart disease during menopause, the cardiovascular advantages of GLP-1 medications are significant. The SELECT trial revealed that participants taking semaglutide for over three years reduced their risk of major cardiovascular events - such as heart attack, stroke, or cardiovascular-related death - by 20%. Overall, semaglutide has been associated with a 26% reduction in major cardiovascular events.

Blood pressure improvements are another noteworthy benefit. A meta-analysis of 33 trials found that combining lifestyle changes with GLP-1 medications led to an average reduction of 3.99 mmHg in systolic blood pressure and 1.11 mmHg in diastolic blood pressure. Additionally, total cholesterol dropped by 5.85 mg/dL, triglycerides by 13.44 mg/dL, and LDL cholesterol by 4.78 mg/dL.

In the SUMMIT trial, tirzepatide demonstrated even more striking results, reducing cardiovascular death or heart failure events by 38% and lowering high-sensitivity C-reactive protein levels by 34.9%.

"The SELECT participants who took semaglutide for more than 3 years lowered their risk of these major adverse cardiovascular events by 20%." – Charles German, MD, Preventive Cardiologist, MedStar Health

These findings highlight the broad health benefits of GLP-1 treatments, paving the way for discussions on how to access these therapies in Singapore.

sbb-itb-5db499f

How to Access GLP-1 Treatments in Singapore

In Singapore, GLP-1 medications are available strictly by prescription after a consultation with a licensed doctor. These treatments come in both oral and injectable forms, and a doctor will evaluate factors such as your medical history, BMI, and any contraindications (e.g. thyroid conditions or pancreatitis) before prescribing them. For Asian women, eligibility often starts at a BMI of 23 kg/m² (considered overweight) or 25 kg/m² (classified as obese), which is lower than the thresholds used internationally.

Telehealth platforms make accessing these treatments much easier. Services like Trimly provide doctor-led programmes that include an initial medical evaluation, customised treatment plans, and unlimited follow-ups - all conducted online. These plans start at S$350 per month and are designed to support patients through the process, including managing side effects and adjusting dosages as needed.

"Having both a weekly injection and a daily tablet option allows us to tailor the approach. Some patients prefer the convenience of once-weekly dosing, while others favour a daily oral routine." – Dr Jana Lim, Family Physician, Singapore Women's Clinic

Telehealth not only simplifies access but also offers flexibility, allowing treatment to be tailored to individual preferences.

Oral GLP-1 Treatment Plans

Oral GLP-1 medications, like Rybelsus (semaglutide), are taken as a daily tablet. To ensure effectiveness, timing is key: the tablet must be taken on an empty stomach with a small sip of water, followed by a 30-minute fasting window before eating or taking other medications. This format is ideal for those who prefer to avoid injections, but it does require strict adherence to the routine for optimal results.

Injectable GLP-1 Treatment Plans

Injectable GLP-1 options are administered subcutaneously in areas like the abdomen (at least 5 cm from the belly button), thigh, or upper arm. Popular choices include Wegovy, Ozempic, and Mounjaro, which are taken weekly, while Saxenda requires daily injections. Clinical studies show semaglutide can lead to up to 15.8% weight loss over 68 weeks, while tirzepatide offers up to 22.5% over 72 weeks. Personalised care during treatment ensures proper rotation of injection sites and helps manage side effects, especially gastrointestinal issues during dose adjustments. Given Singapore’s tropical climate, it’s important to check storage requirements with your provider, as some medications may need refrigeration.

Combining GLP-1 Treatment with Lifestyle Changes

GLP-1 medications work best when paired with tailored diet and exercise routines to support and maintain weight loss. These medications help regulate appetite and blood sugar, but lifestyle changes are what ensure long-term success. For menopausal women, this combination is particularly crucial due to unique metabolic shifts, such as an 8% decrease in resting metabolic rate and a ninefold spike in the hunger hormone ghrelin.

Stopping GLP-1 treatment without adopting sustainable habits often leads to weight regain within a year. By incorporating effective dietary and physical activity strategies, women can maintain their progress over the long haul.

Diet Adjustments with GLP-1 Medications

Menopause brings challenges like a slower metabolism and increased hunger, making nutrition and exercise equally important. Protein intake is especially vital for women using GLP-1 medications during this stage of life. Without enough protein, muscle loss can account for about 20% of total weight loss.

"With diet, you significantly want to increase your protein intake, and incorporate resistance training and weightlifting." – Dr. Jessica Shepherd, board-certified OB-GYN

Focus on high-quality protein sources like fish, lean meats, eggs, tofu, tempeh, and Greek yoghurt. Since GLP-1 medications can reduce daily calorie intake by 16–39%, it’s important to prioritise nutrient-packed foods. Consuming fewer than 1,200 kcal per day may lead to deficiencies in essential vitamins and minerals. Watch for signs like excessive hair loss, flaky skin, or fatigue, which could indicate nutritional gaps.

Shifting from ultra-processed foods to fibre-rich whole foods can also help manage hunger during menopause. Options like quinoa, brown rice, and legumes not only provide energy but also help suppress heightened hunger signals. To minimise gastrointestinal discomfort such as nausea or bloating - common side effects of GLP-1 medications - try eating smaller, more frequent meals and avoid greasy or overly spicy dishes.

Interestingly, women combining GLP-1 medications with Hormone Replacement Therapy (HRT) achieved greater weight loss - 16% of their body weight after 12 months compared to 12% for those not on HRT. This highlights how addressing multiple aspects of menopausal health can yield better results.

Adding Physical Activity to Your Routine

Alongside dietary changes, regular exercise amplifies the effects of GLP-1 medications. Physical activity helps your brain better respond to fullness signals from the gut, enhancing the appetite-regulating benefits of these treatments.

"If you're physically active, your brain is more likely to be receptive to the fullness signals sent from the gut, and therefore, it can help you feel less hungry and support weight loss." – Robbie Puddick, Registered Nutritionist, Second Nature

For menopausal women on GLP-1 therapy, strength training is a must. Without it, up to 20% of weight lost could come from muscle mass. Incorporate resistance exercises, weightlifting, or High-Intensity Interval Training (HIIT) at least twice a week to combat muscle loss and maintain bone density.

Not a fan of the gym? No worries - short bursts of movement throughout the day can make a difference. Try doing 10 push-ups while waiting for your tea to brew or a few star jumps during a quick break. These small efforts add up and help counter the natural drop in energy expenditure during menopause.

Additionally, set daily step goals and stick to simple, repeatable routines rather than sporadic intense workouts. This approach supports consistency and helps reduce visceral fat, which tends to increase as oestrogen levels decline. For example, the SELECT trial found that semaglutide led to a 7.7 cm reduction in waist circumference over 208 weeks, compared to just 1.3 cm with a placebo.

Conclusion: GLP-1 Medications for Menopause Weight Loss

Clinical studies confirm that GLP-1 medications are effective in managing weight gain during menopause. For instance, research shows that postmenopausal women using semaglutide experience a weight loss of 5.8% within just four months. Over extended periods, semaglutide has been shown to result in up to 15.8% weight loss over 68 weeks, while tirzepatide can achieve reductions of up to 22.5% over 72 weeks.

In addition to weight loss, these medications offer broader health benefits. They help improve blood pressure, cholesterol levels, and blood sugar management, with HbA1c reductions ranging between 0.7% and 2.5%. Notably, semaglutide 2.4 mg (Wegovy) is approved by the HSA for reducing major cardiovascular events in overweight or obese adults with established heart disease.

"These medications don't just help people lose weight. They also improve overall health. Many patients see lower blood pressure, better cholesterol levels, and even a reduced risk of type 2 diabetes." – Patrick Welch, PharmD, BCACP, Advanced Clinical Pharmacist, Intermountain Health

Given these wide-ranging health benefits, it’s essential for eligible women to access these treatments under proper medical supervision. GLP-1 medications are prescription-only in Singapore, and this oversight is crucial - not just a formality. Medical guidance ensures safe dose adjustments, helps manage potential side effects, and supports the development of a sustainable, long-term plan that incorporates lifestyle changes alongside medication.

With strong clinical evidence supporting their effectiveness, these treatments address menopause-specific challenges. Trimly provides MOH-approved, doctor-led GLP-1 treatment plans starting from S$350 per month. Their plans include both oral and injectable options, unlimited free follow-ups, and doorstep delivery of medication - offering a convenient and evidence-backed solution for weight management tailored to menopausal women in Singapore.

FAQs

How can GLP-1 medications help with menopause-related weight gain?

GLP-1 medications play a key role in managing weight by making you feel fuller for longer, slowing down digestion, and enhancing how your body responds to insulin. These combined effects help reduce calorie intake and specifically target visceral fat - an issue often tied to abdominal weight gain during menopause.

Research has shown that medications like semaglutide and tirzepatide can significantly reduce both overall weight and waist measurements in post-menopausal women. By addressing the hormonal shifts that occur during menopause, these treatments provide a science-backed approach to managing weight effectively.

What are the potential side effects of GLP-1 medications for managing menopause-related weight gain?

GLP-1 medications, such as semaglutide and tirzepatide, have shown to be effective in managing weight gain during menopause. However, like any medication, they can come with some side effects. Common issues include nausea, vomiting, diarrhoea, bloating, and loss of appetite, particularly in the early stages of treatment. The good news? These symptoms often ease as the dosage is gradually adjusted.

Occasionally, less common side effects may arise, such as injection-site reactions, increased heart rate, gallbladder problems, pancreatitis, or, in rare cases, thyroid tumours. Some people might also notice mild dehydration or cosmetic changes, like a tightening of facial skin. While most side effects are mild and manageable, it’s crucial to consult a doctor if you experience severe nausea, ongoing abdominal pain, or signs of pancreatitis, such as sudden, sharp pain in the upper abdomen that radiates to the back.

In Singapore, Trimly, an MOH-approved telehealth clinic, provides doctor-supervised weight loss treatments using GLP-1 medications. Their personalised care ensures that patients receive professional guidance and close monitoring to manage any potential side effects effectively.

Can GLP-1 medications and hormone therapy be used together for menopause-related weight management?

Combining GLP-1 medications with hormone therapy can be a helpful strategy for tackling menopause-related weight gain. This approach works by addressing two key factors simultaneously: hormonal imbalances and appetite regulation. Together, they may support better weight management and improve metabolic health.

That said, it’s essential to consult a doctor before starting this treatment. A healthcare professional can assess your individual situation and provide tailored advice to maximise benefits while keeping potential risks in check.

Related Blog Posts

• GLP-1 Medications for Weight Loss: How They Work
• GLP-1 vs Traditional Weight Loss Methods Compared
• Best Doctor-Prescribed Weight Loss Medications in 2025
• GLP-1 Dosing for Obese Patients in Singapore